Literature DB >> 18067883

Invariant chain modulates HLA class II protein recycling and peptide presentation in nonprofessional antigen presenting cells.

Azizul Haque1, Laela M Hajiaghamohseni, Ping Li, Katherine Toomy, Janice S Blum.   

Abstract

The expression of MHC class II molecules and the invariant chain (Ii) chaperone, is coordinately regulated in professional antigen presenting cells (APC). Ii facilitates class II subunit folding as well as transit and retention in mature endosomal compartments rich in antigenic peptides in these APC. Yet, in nonprofessional APC such as tumors, fibroblasts and endocrine tissues, the expression of class II subunits and Ii may be uncoupled. Studies of nonprofessional APC indicate class II molecules access antigenic peptides by distinct, but poorly defined pathways in the absence of Ii. Here, investigations demonstrate that nonprofessional APC such as human fibroblasts lacking Ii internalize antigenic peptides prior to the binding of these ligands to recycling class II molecules. By contrast, fibroblast lines expressing Ii favor exogenous peptides binding directly to cell surface class II molecules without a need for ligand internalization. Endocytosis of class II molecules was enhanced in cells lacking Ii compared with Ii-expressing APC. These results suggest enhanced reliance on the endocytic recycling pathway for functional class II presentation in nonprofessional APC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18067883      PMCID: PMC2254578          DOI: 10.1016/j.cellimm.2007.10.005

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  54 in total

1.  Role of APC in the selection of immunodominant T cell epitopes.

Authors:  C Ma; P E Whiteley; P M Cameron; D C Freed; A Pressey; S L Chen; B Garni-Wagner; C Fang; D M Zaller; L S Wicker; J S Blum
Journal:  J Immunol       Date:  1999-12-15       Impact factor: 5.422

Review 2.  Compartmentalization of class II antigen presentation: contribution of cytoplasmic and endosomal processing.

Authors:  Ping Li; Josetta L Gregg; Nan Wang; Delu Zhou; Patrick O'Donnell; Janice S Blum; Victoria L Crotzer
Journal:  Immunol Rev       Date:  2005-10       Impact factor: 12.988

Review 3.  Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression.

Authors:  Robert Busch; Cornelia H Rinderknecht; Sujin Roh; Andrew W Lee; James J Harding; Timo Burster; Tara M C Hornell; Elizabeth D Mellins
Journal:  Immunol Rev       Date:  2005-10       Impact factor: 12.988

4.  Antigen presentation mediated by recycling of surface HLA-DR molecules.

Authors:  V Pinet; M Vergelli; R Martin; O Bakke; E O Long
Journal:  Nature       Date:  1995-06-15       Impact factor: 49.962

5.  Detection of biotinylated cell surface receptors and MHC molecules in a capture ELISA: a rapid assay to measure endocytosis.

Authors:  D N Turvy; J S Blum
Journal:  J Immunol Methods       Date:  1998-03-01       Impact factor: 2.303

6.  Evidence that binding site occupancy is necessary and sufficient for effective major histocompatibility complex (MHC) class II transport through the secretory pathway redefines the primary function of class II-associated invariant chain peptides (CLIP).

Authors:  G Zhong; F Castellino; P Romagnoli; R N Germain
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

7.  Clinical significance of MHC class II-associated invariant chain expression in human gastric carcinoma.

Authors:  Yasuhiro Tamori; Xiaodong Tan; Kazuhiro Nakagawa; Eiji Takai; Junji Akagi; Toshiro Kageshita; Hiroshi Egami; Michio Ogawa
Journal:  Oncol Rep       Date:  2005-10       Impact factor: 3.906

8.  Modification of the amino terminus of a class II epitope confers resistance to degradation by CD13 on dendritic cells and enhances presentation to T cells.

Authors:  X Dong; B An; L Salvucci Kierstead; W J Storkus; A A Amoscato; R D Salter
Journal:  J Immunol       Date:  2000-01-01       Impact factor: 5.422

9.  Immunotherapy of cancer by antisense inhibition of Ii protein, an immunoregulator of antigen selection by MHC class II molecules.

Authors:  Minzhen Xu; Xueqing Lu; Nikoletta L Kallinteris; Yu Wang; Shuzhen Wu; Eric von Hofe; Joseph V Gulfo; Robert E Humphreys; Gilda G Hillman
Journal:  Curr Opin Mol Ther       Date:  2004-04

10.  Effect of decreasing the affinity of the class II-associated invariant chain peptide on the MHC class II peptide repertoire in the presence or absence of H-2M.

Authors:  Karen Honey; Katherine Forbush; Peter E Jensen; Alexander Y Rudensky
Journal:  J Immunol       Date:  2004-04-01       Impact factor: 5.422

View more
  10 in total

1.  Virus-encoded ectopic CD74 enhances poxvirus vaccine efficacy.

Authors:  Crystal C Walline; Sarah N Deffit; Nan Wang; Lynette M Guindon; Victoria L Crotzer; Jianyun Liu; Kristin Hollister; Laurence C Eisenlohr; Randy R Brutkiewicz; Mark H Kaplan; Janice S Blum
Journal:  Immunology       Date:  2014-04       Impact factor: 7.397

2.  Disruption of HLA class II antigen presentation in Burkitt lymphoma: implication of a 47,000 MW acid labile protein in CD4+ T-cell recognition.

Authors:  Jason M God; Dan Zhao; Christine A Cameron; Shereen Amria; Jennifer R Bethard; Azizul Haque
Journal:  Immunology       Date:  2014-07       Impact factor: 7.397

3.  Reduction of myeloid-derived suppressor cells and lymphoma growth by a natural triterpenoid.

Authors:  Faisal F Y Radwan; Azim Hossain; Jason M God; Nathan Leaphart; Michelle Elvington; Mitzi Nagarkatti; Stephen Tomlinson; Azizul Haque
Journal:  J Cell Biochem       Date:  2015-01       Impact factor: 4.429

4.  Mechanisms regulating enhanced human leukocyte antigen class II-mediated CD4 + T cell recognition of human B-cell lymphoma by resveratrol.

Authors:  Faisal F Y Radwan; Lixia Zhang; Azim Hossain; Bently P Doonan; Jason M God; Azizul Haque
Journal:  Leuk Lymphoma       Date:  2011-10-24

5.  Enhancement of HLA class II-restricted CD4+ T cell recognition of human melanoma cells following treatment with bryostatin-1.

Authors:  Dan Zhao; Shereen Amria; Azim Hossain; Kumaran Sundaram; Peter Komlosi; Mitzi Nagarkatti; Azizul Haque
Journal:  Cell Immunol       Date:  2011-08-18       Impact factor: 4.868

6.  Evaluating the Role of HLA-DM in MHC Class II-Peptide Association Reactions.

Authors:  Liusong Yin; Zachary J Maben; Aniuska Becerra; Lawrence J Stern
Journal:  J Immunol       Date:  2015-06-10       Impact factor: 5.422

7.  HLA Class II Antigen Presentation in Prostate Cancer Cells: A Novel Approach to Prostate Tumor Immunotherapy.

Authors:  Bently Patrick Doonan; Azizul Haque
Journal:  Open Cancer Immunol J       Date:  2010-01-01

8.  HLA class II defects in Burkitt lymphoma: bryostatin-1-induced 17 kDa protein restores CD4+ T-cell recognition.

Authors:  Azim Hossain; Jason M God; Faisal F Y Radwan; Shereen Amria; Dan Zhao; Jennifer R Bethard; Azizul Haque
Journal:  Clin Dev Immunol       Date:  2011-11-28

9.  Protective Effects of Estrogen via Nanoparticle Delivery to Attenuate Myelin Loss and Neuronal Death after Spinal Cord Injury.

Authors:  Azizul Haque; Kelsey P Drasites; April Cox; Mollie Capone; Ali I Myatich; Ramsha Shams; Denise Matzelle; Dena P Garner; Mikhail Bredikhin; Donald C Shields; Alexey Vertegel; Naren L Banik
Journal:  Neurochem Res       Date:  2021-07-16       Impact factor: 3.996

Review 10.  Modes of Antigen Presentation by Lymph Node Stromal Cells and Their Immunological Implications.

Authors:  Sachiko Hirosue; Juan Dubrot
Journal:  Front Immunol       Date:  2015-09-08       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.